Scaffold-free, engineered porcine cartilage construct for cartilage defect repair - In vitro and in vivo study

Kwideok Park, Jinsong Huang, Frederick Azar, Ri L. Jin, Byoung Hyun Min, Dong K. Han, Karen Hasty

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

This study introduces an implantable scaffold-free (SF) cartilage tissue construct that is composed of chondrocytes and their self-produced extracellular matrix (ECM). Chondrocytes were isolated from the articular cartilages from knees of domestic pigs (2-week old) and monolayer-cultured for 3-4 days in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum and 50 μg/mL of ascorbic acid. Briefly treated with 0.25% trypsin- ethylenediaminetetraacetic acid (EDTA), an intact chondrocytes/ECM membrane, as a cell sheet was released from the plate bottom and subsequently centrifuged into a pellet-type construct. Each was grown in vitro for up to 5 weeks and subjected to various assays at different time points (1, 7, 14, 21, and 35 days). For in vivo implantation, full-thickness defects (n = 4) were manually created on the femoro-patellar groove of the left porcine knee and 1-week-cultured SF construct was implanted as an allograft for a month. One defect (#1) was an empty control and the remaining three received different recipes; construct only (#2) or 0.25% trypsin/EDTA-treated first and then construct and collagen gel (#3) or construct and collagen gel (#4). While the total cell numbers significantly increased by 2 weeks and then remained stable, cell viability stayed in the mid-70% range through the entire culture period. Biochemical assay found continuous glycosaminoglycan (GAG) accumulation. Histology exhibited that cell distribution was even in the construct and GAG intensity became stronger and uniform with time. Real-time reverse transcription polymerase chain reaction (RT-PCR) results showed that phenotypic stability peaked at 2 weeks, which was arable to that of freshly isolated chondrocytes. Upon analysis of the retrieved implants, some promising results were witnessed in the defects (#3) retaining not only their intact mass but also chondrocytic morphology with lacuna formation.

Original languageEnglish (US)
Pages (from-to)586-596
Number of pages11
JournalArtificial Organs
Volume30
Issue number8
DOIs
StatePublished - Aug 1 2006

Fingerprint

Cartilage
Chondrocytes
Scaffolds
Repair
Swine
Ethylenediaminetetraacetic acid
Glycosaminoglycans
Collagen
Edetic Acid
Trypsin
Defects
Assays
Gels
Extracellular Matrix
Knee
Histology
Ascorbic acid
Polymerase chain reaction
Transcription
Sus scrofa

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomaterials
  • Biomedical Engineering

Cite this

Scaffold-free, engineered porcine cartilage construct for cartilage defect repair - In vitro and in vivo study. / Park, Kwideok; Huang, Jinsong; Azar, Frederick; Jin, Ri L.; Min, Byoung Hyun; Han, Dong K.; Hasty, Karen.

In: Artificial Organs, Vol. 30, No. 8, 01.08.2006, p. 586-596.

Research output: Contribution to journalArticle

Park, Kwideok ; Huang, Jinsong ; Azar, Frederick ; Jin, Ri L. ; Min, Byoung Hyun ; Han, Dong K. ; Hasty, Karen. / Scaffold-free, engineered porcine cartilage construct for cartilage defect repair - In vitro and in vivo study. In: Artificial Organs. 2006 ; Vol. 30, No. 8. pp. 586-596.
@article{835f4b96d3574e048f69030c6814aca7,
title = "Scaffold-free, engineered porcine cartilage construct for cartilage defect repair - In vitro and in vivo study",
abstract = "This study introduces an implantable scaffold-free (SF) cartilage tissue construct that is composed of chondrocytes and their self-produced extracellular matrix (ECM). Chondrocytes were isolated from the articular cartilages from knees of domestic pigs (2-week old) and monolayer-cultured for 3-4 days in Dulbecco's modified Eagle's medium supplemented with 10{\%} fetal calf serum and 50 μg/mL of ascorbic acid. Briefly treated with 0.25{\%} trypsin- ethylenediaminetetraacetic acid (EDTA), an intact chondrocytes/ECM membrane, as a cell sheet was released from the plate bottom and subsequently centrifuged into a pellet-type construct. Each was grown in vitro for up to 5 weeks and subjected to various assays at different time points (1, 7, 14, 21, and 35 days). For in vivo implantation, full-thickness defects (n = 4) were manually created on the femoro-patellar groove of the left porcine knee and 1-week-cultured SF construct was implanted as an allograft for a month. One defect (#1) was an empty control and the remaining three received different recipes; construct only (#2) or 0.25{\%} trypsin/EDTA-treated first and then construct and collagen gel (#3) or construct and collagen gel (#4). While the total cell numbers significantly increased by 2 weeks and then remained stable, cell viability stayed in the mid-70{\%} range through the entire culture period. Biochemical assay found continuous glycosaminoglycan (GAG) accumulation. Histology exhibited that cell distribution was even in the construct and GAG intensity became stronger and uniform with time. Real-time reverse transcription polymerase chain reaction (RT-PCR) results showed that phenotypic stability peaked at 2 weeks, which was arable to that of freshly isolated chondrocytes. Upon analysis of the retrieved implants, some promising results were witnessed in the defects (#3) retaining not only their intact mass but also chondrocytic morphology with lacuna formation.",
author = "Kwideok Park and Jinsong Huang and Frederick Azar and Jin, {Ri L.} and Min, {Byoung Hyun} and Han, {Dong K.} and Karen Hasty",
year = "2006",
month = "8",
day = "1",
doi = "10.1111/j.1525-1594.2006.00267.x",
language = "English (US)",
volume = "30",
pages = "586--596",
journal = "Artificial Organs",
issn = "0160-564X",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Scaffold-free, engineered porcine cartilage construct for cartilage defect repair - In vitro and in vivo study

AU - Park, Kwideok

AU - Huang, Jinsong

AU - Azar, Frederick

AU - Jin, Ri L.

AU - Min, Byoung Hyun

AU - Han, Dong K.

AU - Hasty, Karen

PY - 2006/8/1

Y1 - 2006/8/1

N2 - This study introduces an implantable scaffold-free (SF) cartilage tissue construct that is composed of chondrocytes and their self-produced extracellular matrix (ECM). Chondrocytes were isolated from the articular cartilages from knees of domestic pigs (2-week old) and monolayer-cultured for 3-4 days in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum and 50 μg/mL of ascorbic acid. Briefly treated with 0.25% trypsin- ethylenediaminetetraacetic acid (EDTA), an intact chondrocytes/ECM membrane, as a cell sheet was released from the plate bottom and subsequently centrifuged into a pellet-type construct. Each was grown in vitro for up to 5 weeks and subjected to various assays at different time points (1, 7, 14, 21, and 35 days). For in vivo implantation, full-thickness defects (n = 4) were manually created on the femoro-patellar groove of the left porcine knee and 1-week-cultured SF construct was implanted as an allograft for a month. One defect (#1) was an empty control and the remaining three received different recipes; construct only (#2) or 0.25% trypsin/EDTA-treated first and then construct and collagen gel (#3) or construct and collagen gel (#4). While the total cell numbers significantly increased by 2 weeks and then remained stable, cell viability stayed in the mid-70% range through the entire culture period. Biochemical assay found continuous glycosaminoglycan (GAG) accumulation. Histology exhibited that cell distribution was even in the construct and GAG intensity became stronger and uniform with time. Real-time reverse transcription polymerase chain reaction (RT-PCR) results showed that phenotypic stability peaked at 2 weeks, which was arable to that of freshly isolated chondrocytes. Upon analysis of the retrieved implants, some promising results were witnessed in the defects (#3) retaining not only their intact mass but also chondrocytic morphology with lacuna formation.

AB - This study introduces an implantable scaffold-free (SF) cartilage tissue construct that is composed of chondrocytes and their self-produced extracellular matrix (ECM). Chondrocytes were isolated from the articular cartilages from knees of domestic pigs (2-week old) and monolayer-cultured for 3-4 days in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum and 50 μg/mL of ascorbic acid. Briefly treated with 0.25% trypsin- ethylenediaminetetraacetic acid (EDTA), an intact chondrocytes/ECM membrane, as a cell sheet was released from the plate bottom and subsequently centrifuged into a pellet-type construct. Each was grown in vitro for up to 5 weeks and subjected to various assays at different time points (1, 7, 14, 21, and 35 days). For in vivo implantation, full-thickness defects (n = 4) were manually created on the femoro-patellar groove of the left porcine knee and 1-week-cultured SF construct was implanted as an allograft for a month. One defect (#1) was an empty control and the remaining three received different recipes; construct only (#2) or 0.25% trypsin/EDTA-treated first and then construct and collagen gel (#3) or construct and collagen gel (#4). While the total cell numbers significantly increased by 2 weeks and then remained stable, cell viability stayed in the mid-70% range through the entire culture period. Biochemical assay found continuous glycosaminoglycan (GAG) accumulation. Histology exhibited that cell distribution was even in the construct and GAG intensity became stronger and uniform with time. Real-time reverse transcription polymerase chain reaction (RT-PCR) results showed that phenotypic stability peaked at 2 weeks, which was arable to that of freshly isolated chondrocytes. Upon analysis of the retrieved implants, some promising results were witnessed in the defects (#3) retaining not only their intact mass but also chondrocytic morphology with lacuna formation.

UR - http://www.scopus.com/inward/record.url?scp=33746397618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746397618&partnerID=8YFLogxK

U2 - 10.1111/j.1525-1594.2006.00267.x

DO - 10.1111/j.1525-1594.2006.00267.x

M3 - Article

C2 - 16911312

AN - SCOPUS:33746397618

VL - 30

SP - 586

EP - 596

JO - Artificial Organs

JF - Artificial Organs

SN - 0160-564X

IS - 8

ER -